List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 37 studies with search of:   "Neurofibroma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas
Condition: Neurofibroma
Intervention: Drug: LS11
2 Suspended Study of PEG-Intron for Plexiform Neurofibromas
Condition: Plexiform Neurofibroma
Intervention: Drug: PEG-Intron
3 Recruiting Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
Conditions: Neurofibromatosis Type 1;   Cutaneous Neurofibromas
Intervention: Drug: Ranibizumab
4 Recruiting Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
Conditions: Dermal Neurofibromas;   Neurofibromatosis Type 1
Intervention:
5 Active, not recruiting Study of Plexiform Neurofibromas in Neurofibromatosis Type 1
Conditions: Neurofibroma, Plexiform;   Neurofibromatosis Type I
Intervention:
6 Recruiting AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: cediranib maleate
7 Recruiting Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Interventions: Drug: fludeoxyglucose F 18;   Drug: gadopentetate dimeglumine;   Procedure: magnetic resonance imaging;   Procedure: positron emission tomography;   Procedure: radionuclide imaging
8 Completed Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: pirfenidone
9 Active, not recruiting Pirfenidone in Treating Young Patients With Neurofibromatosis Type I and Recurrent or Progressive Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: pirfenidone
10 Recruiting Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Interventions: Drug: methotrexate;   Drug: vinblastine
11 Recruiting Tipifarnib in Preventing Cancer in Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition;   Sarcoma
Interventions: Drug: placebo;   Drug: tipifarnib
12 Recruiting Sirolimus in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed By Surgery
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: sirolimus
13 Active, not recruiting Natural History Study of Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Procedure: magnetic resonance imaging
14 Recruiting PEG-Interferon Alfa-2b in Treating Young Patients With Unresectable Plexiform Neurofibromas Associated With Neurofibromatosis Type 1
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: PEG-interferon alfa-2b
15 Recruiting Sorafenib in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: sorafenib tosylate
16 Recruiting Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Condition: Cancer
Intervention:
17 Active, not recruiting PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
Conditions: Neoplasm of Uncertain Malignant Potential;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: PEG-interferon alfa-2a
18 Recruiting A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
Condition: Neurofibromatosis Type 1
Intervention: Drug: Sirolimus, Rapamycin
19 Recruiting Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
Condition: Neurofibromatosis Type I
Intervention:
20 Recruiting Studying Changes Over Time in Patients With Neurofibromatosis Type 1 and Their Healthy Siblings
Conditions: Bone Cancer;   Brain and Central Nervous System Tumors;   Precancerous/Nonmalignant Condition;   Sarcoma
Interventions: Drug: fludeoxyglucose F 18;   Procedure: cognitive assessment;   Procedure: digital image analysis;   Procedure: gene expression analysis;   Procedure: magnetic resonance imaging;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment

Previous Page Studies Shown (1-20) Next (21-37)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services